Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data?
Eur Heart J
.
2021 Nov 21;42(44):4589-4591.
doi: 10.1093/eurheartj/ehab667.
Authors
Claudio Borghi
1
,
Giulia Fiorini
1
Affiliation
1
Department of Medical and Surgical Sciences, IRCCS S.Orsola, University of Bologna, Bologna, Italy.
PMID:
34618013
DOI:
10.1093/eurheartj/ehab667
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cardiovascular Diseases*
Gout* / drug therapy
Humans
Pharmaceutical Preparations*
Trust
Uric Acid
Substances
Pharmaceutical Preparations
Uric Acid